UnitedHealth leans harder into Medicare Advantage as Q3 profits climb
UnitedHealth Group raised its 2026 earnings outlook for the third time this year after posting a sharp rise in third-quarter profit, even as revenue slipped modestly. The performance gives the insurer fresh room to press ahead with a Medicare Advantage strategy built on tighter plan design, narrower membership, and a heavier tilt toward more profitable products.
The company reported profit of $4.1 billion in the quarter, up 75% from a year earlier, on revenue of $112.7 billion, down 0.4%. Those results landed above Wall Street expectations and reinforced the market’s view that the company’s turnaround is gaining traction after a bruising stretch of elevated medical costs and utilization across the health insurance sector.
The most consequential metric in the quarter was the company’s medical loss ratio, which fell to 88.4% from 89.9% a year earlier. In insurance, a lower ratio means a larger share of premium dollars is being retained after claims spending, and that shift flowed through directly to margins. UnitedHealthcare, the insurance arm, generated $2.8 billion in operating profit, roughly $1 billion more than in the prior year, while Optum Health posted $735 million in operating income, nearly 18 times the level of the same period last year.
Margin repair is reshaping the Medicare Advantage book
UnitedHealthcare’s recovery has come at a cost. The insurer has cut benefits, raised premiums, and dropped unprofitable plans, allowing it to rebuild margins while shedding members it does not want at current reimbursement levels. That approach is set to continue in 2026, when the company expects to lose more than 1 million enrollees in its privatized Medicare business.
The logic is straightforward: when reimbursement is under pressure, the fastest route back to profitability is often not growth for its own sake, but a more selective risk pool. By trimming richer plan offerings and focusing on lower-cost structures, UnitedHealth is trying to match premiums more closely to expected claims. Bobby Hunter, president of the insurance division, said the company expects UnitedHealthcare to finish 2026 at the high end of its 2% to 4% margin range.
A narrower portfolio is also setting the stage for 2027. UnitedHealthcare has cut hundreds of Medicare Advantage plans, trimmed benefits, and pushed more cost responsibility onto members. Traditional plans with broader provider networks were hit hardest, while narrower-network HMO products and special needs plans received more emphasis. Special needs plans, which generally cover chronically ill beneficiaries or people dually eligible for Medicare and Medicaid, often carry higher per-member margins than standard MA products.
The shift is not subtle.
Higher margins, but a weaker quality scorecard
The company’s strategy is improving earnings, yet it is also dragging on quality bonuses tied to Medicare Advantage star ratings. For 2027, the share of UnitedHealthcare members in plans rated at least 4 stars fell to 68% from 81% for 2026. Those ratings matter because they influence bonus payments and help plans compete for members in future payment years.
Management said the decline was expected after the company pulled back plan generosity to restore margins. Hunter said there was always some risk of star pressure tied to the benefit repositioning used for 2026. Chief executive Stephen Hemsley added that the membership mix should improve over 2027, with the share of members in 4-star-or-better plans projected to be closer to 75% by the end of the year.
For Medicare Advantage, the tension is clear: richer benefits can support ratings and enrollment, but they also compress margins when utilization rises or reimbursement lags. UnitedHealth has chosen the latter path, accepting a shorter-term hit to membership and quality scores in exchange for more durable earnings power.
Commercial pressure and Medicaid strain remain in view
The company’s other lines of business are not moving in the same direction. UnitedHealthcare’s employer-sponsored plans faced unexpectedly high spending for the second quarter in a row, with providers billing more aggressively and specialty drug costs continuing to climb. Hemsley said the biggest drain is the out-of-network dispute process under the No Surprises Act, which is forcing the company to pay outsized awards in arbitration.
In some regions, those payouts account for nearly 6% of UnitedHealthcare’s total medical spend, a burden Hemsley described as “ongoing abuse” by some clinician groups. The company plans to keep pressing policymakers and regulators to rein in what it views as excessive awards that distort the intended function of the law.
Medicaid is still under strain as well. Medicaid CEO Mike Cotton described a “stubborn” gap between state funding and elevated utilization, and UnitedHealth expects that business to run at a -1% margin this year before improving in 2027 and beyond. Here again, the issue is not simply volume. It is the spread between what the company is paid and the cost of the care it is covering, especially as utilization remains elevated.
Investors are backing the turnaround, but the mix is fragile
The broader market has rewarded UnitedHealth’s steady guidance raises. Analysts at Morgan Stanley described the quarter as another solid result that reinforces confidence in the company’s trajectory. The insurer lifted its adjusted earnings outlook to at least $20.50 per share, up from a previous range of $19.50 to $20.
Still, the recovery rests on a narrow set of assumptions. Medicare Advantage margins must keep improving. Commercial spending must be contained. Medicaid losses must narrow. And the star ratings decline, which will affect 2028 revenue, cannot deepen further without compromising the economics of the growth strategy.
UnitedHealth’s third quarter shows how aggressively the company is willing to trade membership for margin. The next test is whether that trade can hold once enrollment pressure, quality-score erosion, and arbitration costs collide in the same year.